Kennett Square, PA, United States of America

Zhongjiang Jia

This inventor holds 49 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Inhibitor Chemistry. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Hoffmann-La Roche Inc.. Active years: 2017-2026.

USPTO Granted Patents = 49 

% Patents Active = 91.8

 

 

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 329(Granted Patents)


Location History:

  • Kennett Square, PA (US) (2017 - 2024)
  • Kenneth Square, PA (US) (2018 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
FGFR Inhibitor
BET Inhibitor
PD-1/PD-L1 Inhibitor
JAK Inhibitor
PI3K Inhibitor
Pim Kinase Inhibitor
LSD1 Inhibitor
HPK1 Inhibitor
Crystalline Forms
Solid Forms
Salts
Processes
49 patents (USPTO):Explore Patents

Title: Inventor Zhongjiang Jia - Revolutionizing Technology

Introduction: Zhongjiang Jia, a visionary inventor based in Kennett Square, PA (US), is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Zhongjiang Jia holds several patents in the areas of artificial intelligence, renewable energy, and nanotechnology, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Zhongjiang Jia has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Zhongjiang Jia has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and excellence in all his projects.

Conclusion: Zhongjiang Jia's passion for innovation, coupled with his relentless drive to push the boundaries of technology, cements his legacy as a pioneering inventor shaping the future of the tech industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…